BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26387111)

  • 1. Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.
    Korsak M; Kozyreva T
    Adv Exp Med Biol; 2015; 870():401-21. PubMed ID: 26387111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
    Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
    ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases.
    Coskuner O; Uversky VN
    Prog Mol Biol Transl Sci; 2019; 166():145-223. PubMed ID: 31521231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.
    Kuhn AJ; Raskatov J
    J Alzheimers Dis; 2020; 74(1):43-53. PubMed ID: 32176648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.
    Gadhave K; Gehi BR; Kumar P; Xue B; Uversky VN; Giri R
    Cell Mol Life Sci; 2020 Oct; 77(20):4163-4208. PubMed ID: 31894361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear-induced amyloid formation of IDPs in the brain.
    Trumbore CN
    Prog Mol Biol Transl Sci; 2019; 166():225-309. PubMed ID: 31521233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic approaches unraveling regulation and aggregation of intrinsically disordered β-amyloids implicated in Alzheimer's disease.
    Kumari A; Rajput R; Shrivastava N; Somvanshi P; Grover A
    Int J Biochem Cell Biol; 2018 Jun; 99():19-27. PubMed ID: 29571707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
    Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
    J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
    Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
    Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
    Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
    Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
    Condello C; Stöehr J
    Neurobiol Dis; 2018 Jan; 109(Pt B):191-200. PubMed ID: 28359847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide.
    Löhr T; Kohlhoff K; Heller GT; Camilloni C; Vendruscolo M
    ACS Chem Neurosci; 2022 Jun; 13(12):1738-1745. PubMed ID: 35649268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.